NEW YORK (GenomeWeb News) – Molecular diagnostic testing is making headway into decentralized settings, such as hospitals and smaller labs, despite continuing obstacles to their widespread adoption, industry executives said yesterday at the Piper Jaffray Conference held here.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.